ArticleFrontiers in medicine2025
Correlation between metabolic syndrome indicators and locomotive syndrome in Chinese geriatric oncology inpatients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the correlation between metabolic syndrome (MS) indicators and locomotive syndrome (LS) in geriatric oncology inpatients. Methods: This study enrolled 430 geriatric oncology inpatients at risk of LS, admitted to the Department of Oncology at Affiliated Hospital of Jiangnan University from January 2024 and December 2024. Waist circumference, diastolic blood pressure, systolic blood pressure, total cholesterol (TC), triacylglycerols (TG), fasting glucose, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured as MS indicators. The Geriatric Locomotive Function Scale (GLFS-25) was used to assess LS. Subjects were classified into two groups: those with LS (322 cases) and those without (87 cases), to analyze the correlation between MS indicators and LS. Results: 409 geriatric oncology inpatients completed the study. One-way linear regression analysis revealed that waist circumference, systolic blood pressure, diastolic blood pressure, TG, and LDL-C were positively correlated with GLFS-25 ( Conclusion: Certain risk factors for MS are associated with increased GLFS-25 scores and the development of LS in geriatric oncology inpatients. Screening for LS is beneficial for the early diagnosis of MS and using LS as a focal point for intervention offers new insights into the comprehensive rehabilitation of geriatric oncology patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.